Skip to content

New Zealand approves MDMA to treat severe PTSD

scienceSep 4, 202613170

New Zealand’s medicines regulator Medsafe has authorised two psychiatrists to prescribe pharmaceutical‑grade MDMA for people with severe post‑traumatic stress disorder. The approval makes New Zealand the second country after Australia in 2023 to permit MDMA-assisted therapy for PTSD. Wellington’s Ministry of Health said MDMA will be given only in controlled clinical settings, combined with psychotherapy, and patients will not be supplied drugs to take home. Deputy Prime Minister David Seymour said MDMA can be very effective and framed the decision as opening access to innovative treatments. The Guardian notes the US Food and Drug Administration rejected legalising MDMA’s medicinal use in 2024, and that conventional US pharmacological options for PTSD are limited to two antidepressants that take months to work. A recent Israeli study cited by the article reported MDMA use at a music festival helped cushion trauma for some attendees after the 7 October attacks.

1 source